Osage University Partners (OUP) | Activity | F4

Team Portfolio Raise Champions Essays

F4/Osage University Partners (OUP)/Activity

Osage University Partners (OUP) Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Exit

Portfolio company DICE Therapeutics agreed to be acquired by Lilly.

DICE Therapeutics

DICE Therapeutics Osage University Partners (OUP)

Added recently

Milestone

Portfolio company Tessera Labs raised $60M led by Andreessen Horowitz.

Tessera Labs

Tessera Labs Osage University Partners (OUP)

businesswire.comMAY 2026

MAY 2026

Team Change

OUP appointed Gibb Witham as Venture Partner.

Gibb Witham appointed Venture Partner

Osage University Partners (OUP)

businesswire.comMAY 2026

MAY 2026

Milestone

Portfolio company Terremoto Biosciences closed a $108M Series C.

Terremoto Biosciences

Terremoto Biosciences Osage University Partners (OUP)

businesswire.comAPR 2026

APR 2026

Milestone

Portfolio company Eridu emerged from stealth with over $200M in funding.

Eridu

Eridu Osage University Partners (OUP)

businesswire.comMAR 2026

MAR 2026

Team Change

OUP promoted Manny Stockman to Managing Partner, Mitra Miri to Partner and Beth Grafstrom to SVP Finance.

Manny Stockman promoted to Managing Partner

Osage University Partners (OUP)

businesswire.comJAN 2026

JAN 2026

New Fund

University of Pennsylvania, BioNTech and OUP launched a $50M life sciences fund.

$50M Penn / BioNTech / OUP life sciences fund

Osage University Partners (OUP)

businesswire.comJAN 2026

JAN 2026